Clinical Performance and Safety of Cerviron® Vaginal Ovules in the Management of Symptomatic Cervical Lesions: A National, Multicentric Study
- PMID: 39717511
- PMCID: PMC11665293
- DOI: 10.1016/j.curtheres.2024.100762
Clinical Performance and Safety of Cerviron® Vaginal Ovules in the Management of Symptomatic Cervical Lesions: A National, Multicentric Study
Abstract
Background: Cervical ectropion is frequently associated with vaginal symptoms requiring therapeutic intervention. However, no scientific consensus has been reached regarding the use of local re-epithelialization therapy to prevent severe bleeding, wound inflammation, and infection of cervical lesions.
Objective: The aim of our study was to investigate the aspect of the cervix by colposcopy after a 3-month treatment with an intravaginal medical device in the context of postoperative care of the symptomatic ectropion. The study analyzed additional clinical parameters, such as the evolution of primary and secondary inflammation and the degree of cervical epithelialization as secondary objectives.
Methods: Our pilot study included 27 participants with symptomatic cervical ectopy, with or without an associated human papillomavirus infection. The treatment protocol consisted of the monthly delivery of the medical device intravaginally, during day 1 to day 15, with a total study duration of 3 months.
Results: The medical device had a positive impact on cervical epithelialization, in terms of aspect of the cervix returning to normal for 100% of the participants. Between study visits, it was observed that primary inflammation was reduced by 85.19%, whereas vaginal ulceration, colpitis, and leukorrhea were improved by 70.37%, 81.48%, and by 66.67%, respectively.
Conclusions: The degree of cervical epithelialization reflects how well the cervix has healed after an injury or infection. The device showed clinical performance in complete re-epithelialization after surgical procedures. Moreover, our study findings suggest that supportive treatment with this intravaginal medical device can be recommended for cervical wound healing in patients with human papillomavirus infection. ClinicalTrials.gov identifier: NCT04735718.
Keywords: cervical ectopy; cervical epithelialization; human papillomavirus; medical device; postoperative care; vaginal bleeding.
© 2024 The Author(s).
Conflict of interest statement
R.P. is currently employed at MDX Research. A.R.P. provided statistical input while working for MDX Research. MDX Research was involved in the study design, site selection, collection, statistical analysis, and preparation of the manuscript. The authors have indicated that they have no other conflicts of interest regarding the content of this article.
Figures
Similar articles
-
Real‑world study of Cerviron® vaginal ovules in the treatment of cervical lesions of various etiologies.Biomed Rep. 2023 Jul 7;19(2):54. doi: 10.3892/br.2023.1618. eCollection 2023 Aug. Biomed Rep. 2023. PMID: 37546352 Free PMC article.
-
Clinical Performance and Safety of Vaginal Ovules in the Local Treatment of Nonspecific Vaginitis: A National, Multicentric Clinical Investigation.Clin Ther. 2023 Sep;45(9):873-880. doi: 10.1016/j.clinthera.2023.06.023. Epub 2023 Jul 18. Clin Ther. 2023. PMID: 37474354
-
Collagen-Based Ovule Therapy Reduces Inflammation and Improve Cervical Epithelialization in Patients with Fungal, Viral, and Bacterial Cervico-Vaginitis.Medicina (Kaunas). 2023 Aug 18;59(8):1490. doi: 10.3390/medicina59081490. Medicina (Kaunas). 2023. PMID: 37629780 Free PMC article.
-
Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.J Obstet Gynaecol Res. 2021 May;47(5):1624-1630. doi: 10.1111/jog.14733. Epub 2021 Mar 23. J Obstet Gynaecol Res. 2021. PMID: 33754436 Review.
-
Mechanical dilatation of the cervix during elective caeserean section before the onset of labour for reducing postoperative morbidity.Cochrane Database Syst Rev. 2018 Aug 10;8(8):CD008019. doi: 10.1002/14651858.CD008019.pub3. Cochrane Database Syst Rev. 2018. PMID: 30096215 Free PMC article.
References
-
- Lu Z, Chen H, Zheng X-M, Chen M-L. Expression and clinical significance of high risk human papillomavirus and invasive gene in cervical carcinoma. Asian Pac J Trop Med. 2017;10:195–200. - PubMed
-
- Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci. (Lond) 2017;131:2201–2221. - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical